Stay updated on Benralizumab in HES: Efficacy and Safety Clinical Trial
Sign up to get notified when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.

Latest updates to the Benralizumab in HES: Efficacy and Safety Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows a 403 Forbidden error with minimal navigation, replacing the previously visible study-record content. The detailed study information appears removed or inaccessible, indicating a site access issue rather than a content update.SummaryDifference19%

- Check19 days agoChange DetectedRevision: v3.7.0 has been added and Revision: v3.6.6 has been removed. This reflects an update to the version of the study documentation referenced on the page.SummaryDifference0.0%

- Check33 days agoChange DetectedA new page revision label 'Revision: v3.6.6' was added and the previous label 'Revision: v3.6.5' was removed, indicating a minor update to the page's versioning or documentation metadata.SummaryDifference0.0%

- Check40 days agoChange DetectedTwo NIH grant/contract identifiers for 2019 and 2023 were added to the study record, indicating additional funding acknowledgments associated with the trial.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision label updated from v3.6.4 to v3.6.5 on the page, indicating an incremental update to the page template or content handling. No user-facing content changes are indicated by this update.SummaryDifference0.0%

- Check69 days agoChange DetectedA revision tag was updated from v3.6.3 to v3.6.4, representing an update to the document version used on the study page. This is an administrative versioning change to the study materials.SummaryDifference0.0%

Stay in the know with updates to Benralizumab in HES: Efficacy and Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Benralizumab in HES: Efficacy and Safety Clinical Trial page.